Ignite Creation Date:
2024-05-06 @ 4:06 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04871945
Status:
COMPLETED
Last Update Posted:
2022-03-17
First Post:
2021-04-29
Brief Title:
Protective Antibody Level After COVID-19 Vaccination Among Patients Under Hemodialysis
Sponsor:
Hanyang University Seoul Hospital
Organization:
Hanyang University Seoul Hospital
Study Overview
Official Title:
Evaluation of Protective Antibody Production After COVID-19 Vaccination Among Patients Under Hemodialysis
Status:
COMPLETED
Status Verified Date:
2021-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the study is to evaluate the level of neutralizing antibody against SARS-CoV-2 after COVID-19 vaccination in patients under hemodialysis To this end the level of neutralizing antibody of patients under hemodialysis is compared to that of healthy population
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None